Inborn Errors of Carbohydrate Metabolism

Inborn Errors of Carbohydrate Metabolism

Overview of Carbohydrate Metabolism

  • Key Components:

    • Hexosemonophosphate Shunt - A metabolic pathway that generates NADPH and ribose-5-phosphate, essential for fatty acid synthesis and nucleotide production.

    • Glycolysis

    • Gluconeogenesis

    • Glycogenesis

    • Glycogenolysis

    • Krebs Cycle

    • Lactic Acid Production

    • Influence of Noncarbohydrate Sources

Glycogen Storage Diseases (GSD) Overview

  • Definition:

    • Inherited metabolic disorders caused by enzyme deficiencies affecting glycogen breakdown or synthesis.

    • A cannot go to B

      • Accumulation of A and deficiency in B

Types of Glycogen Storage Diseases
  1. GSD Type I - Von Gierke’s

    • Affected Organs: Liver/Kidneys

  2. GSD Type II - Pompe’s

    • Affected Organs: Skeletal/Cardiac Muscle

  3. GSD Type III - Cori’s

    • Affected Organs: Liver/Muscle

  4. GSD Type IV - Andersen’s

    • Affected Organs: Liver/Muscle

  5. GSD Type V - McArdle’s

    • Affected Organs: Muscle

  6. GSD Type VI - Her's

    • Affected Organs: Liver

  7. GSD Type VII - Tarui’s

    • Affected Organs: Muscle, RBCs

Glycogenolysis

GSD Type I - Von Gierke's Disease
  • Enzyme Deficiency: Glucose-6-phosphatase

  • Affects liver and kidneys

  • Metabolic Consequences:

    • Accumulation of Glycogen

    • Impaired conversion of Glycogen to Glucose

  • Symptoms:

    • Hypoglycemia

    • Hepatomegaly - an enlargement of the liver due to excessive glycogen accumulation, often seen in conditions affecting glycogen metabolism.

    • Lactic acidosis - a condition characterized by an accumulation of lactic acid in the body, often resulting from reduced oxygen levels or increased production such as during hypoglycemic episodes in certain metabolic disorders.

    • Hyperlipidemia

    • Hyperuricemia

    • Stunted growth

  • Treatment Strategies:

    • Frequent glucose/starch intake every 3-4 hours

    • Nocturnal nasogastric glucose administration

GSD Type III - Cori’s Disease
  • Enzyme Deficiency: α-1,6 glucosidase (debranching enzyme)

  • Symptoms:

    • Milder version than Von Gierke

    • Hepatomegaly

    • Hypoglycemia

    • Muscle weakness (myopathy)

    • Cardiomyopathy

  • Treatment Strategies:

    • Continuous glucose source

GSD Type IV - Andersen’s Disease
  • Enzyme Deficiency: α-1,6 branching enzyme

  • Symptoms:

    • Enlarged liver & spleen

    • Liver cirrhosis

    • High mortality rate generally before age 5

GSD Type V - McArdle’s Disease
  • Enzyme Deficiency: Muscle glycogen phosphorylase

  • Clinical Symptoms:

    • Exercise intolerance

    • Muscle fatigue

    • Muscle pain

    • Red-brown urine

      • Myoglobinuria

        • Myoglobin in urine

      • Rhabomyolysis: A condition characterized by the breakdown of muscle tissue, resulting in the release of myoglobin into the bloodstream, which can cause myoglobinuria. Death of muscle fibers → release of myoglobin

    • Possible renal failure

  • Treatment Strategies:

    • No definitive treatment;

    • Avoid strenuous exercise

    • Administration of sucrose

    • Consideration of creatine supplements

      • Phosphocreatine - a high-energy compound that plays a critical role in energy metabolism and is often used to replenish ATP levels during short bursts of intense activity.

    • High-protein diet

For all of those, treatment is introducing glucose or substitute for glucose

GSD Type VI - Her's Disease
  • Enzyme Deficiency: Liver glycogen phosphorylase

  • Clinical Symptoms:

    • Milder than GSD Type I with less severe hypoglycemia

GSD Type VII - Tarui’s Disease
  • Enzyme Deficiency: Phosphofructokinase-1 in muscle and RBCs

  • Clinical Symptoms:

    • Similar to McArdle’s disease

    • Hemolytic anemia

    • Jaundice

  • Treatment Strategies:

    • Avoid strenuous exercise

Pyruvate Kinase Deficiency
  • Affected Cells: Red blood cells

  • Clinical Symptoms:

    • Hemolytic anemia

    • Fatigue

    • Liver failure

    • Jaundice

    • Gallstones

  • Treatment Strategies:

    • Blood transfusion

    • Splenectomy (removal of the spleen)

      • Spleen acts as blood filter

Summary of Glycogen Storage Diseases

  • Common Symptoms Across GSDs:

  • Overview of Enzyme Deficiencies by GSD Type:

    • I - Glucose-6-Phosphatase

    • II - Lysosomal α-Glucosidase

    • III - Debranching enzyme

    • IV - Branching enzyme

    • V - Muscle phosphorylase

    • VI - Liver phosphorylase

Disorders of Other Monosaccharides**

Galactose Metabolism Disorders
  • Pathway Components:

    • Galactose

    • Galactose-1-phosphate

    • UDP-galactose

    • UDP-glucose

GALK - Galactose kinase def., an enzyme that catalyzes the phosphorylation of galactose to galactose-1-phosphate.

GALT - Galactose-1-phosphate uridylyltransferase def., an enzyme that converts galactose-1-phosphate to glucose-1-phosphate.

GALE - UDP-galactose-4-epimerase def.

  • Galactosemia Types:

    1. Galactokinase deficiency

    2. Deficiency of Galactose-1-phosphate uridyl transferase

    • Classically severe, Duarte is milder

  1. UDP-galactose-4-epimerase deficiency

  • Classic Galactosemia Treatment:

    • Lifelong lactose-free diet to avoid milk and milk products; consider alternatives like soy, oat, almond milk.

Fructose Metabolism Disorders
  • Types of Disorders:

    1. Essential fructosuria

      1. Fructose in the urine

    2. Fructosemia (hereditary fructose intolerance)

      1. A more severe disorder caused by a deficiency in the enzyme aldolase B, leading to the accumulation of fructose-1-phosphate in the liver, which can cause severe hypoglycemia, vomiting, and liver damage if fructose is ingested.

  • Fructose Metabolism Pathway:

    • Fructose is phosphorylated by fructokinase to produce fructose-1-phosphate (F1-P)

Clinical Symptoms of Hereditary Fructose Intolerance

  • Symptoms:

    • Strong aversion to sweet foods

    • Abdominal pain

    • Vomiting

    • Hypoglycemia caused by prolonged ingestion leading to hepatic and/or renal failure

  • Treatment Strategies:

    • Lifelong fructose-free diet; avoidance of sucrose and sweeteners.